Concepedia

Toshiyuki Ishiwata

TI

Statistics

Publications

130

Citations

6.8K

H-Index

50

Active since

1983

Affiliations

Nippon Medical School(Current)

Tokyo Metropolitan Geriatric Hospital

Tokyo Metropolitan Institute of Gerontology

University of California, Irvine

Nippon Veterinary and Life Science University

Toshiyuki Ishiwata is an author at Nippon Medical School specializing in medicine, oncology, and molecular oncology.

Publications per year

1983–2023

130

Publications

130

The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer.

Jörg Kleeff, Toshiyuki Ishiwata, Asli Kumbasar et al. · Journal of Clinical Investigation · 1998 · 369 citations · Full text

Life Sciences, Cell Biology, Oncology +16

Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression.

Jun Itakura, Toshiyuki Ishiwata, Helmut Friess et al. · PubMed · 1997 · 271 citations

Medicine, Oncology, Pathology +17

The TGF-β signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer

Jörg Kleeff, Toshiyuki Ishiwata, Haruhisa Maruyama et al. · Oncogene · 1999 · 258 citations

Medicine, Cancer Biology, Oncology +13

Vascular Endothelial Growth Factor Enhances Glomerular Capillary Repair and Accelerates Resolution of Experimentally Induced Glomerulonephritis

Yukinari Masuda, Akira Shimizu, Takahiro Mori et al. · American Journal Of Pathology · 2001 · 236 citations · Full text

Medicine, Nephrology, Pathobiology +12

Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancer

Jun Itakura, Toshiyuki Ishiwata, Ben Shen et al. · International Journal of Cancer · 2000 · 233 citations

Medicine, Cancer Biology, Oncology +17

1–5 of 130